Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S V Rajkumar

Polymorphism of the Erythropoietin Gene Promotor and the Development of Myelodysplastic Syndromes Subsequent to Multiple Myeloma

Leukemia

English

Suppression of Uninvolved Immunoglobulins Defined by Heavy/Light Chain Pair Suppression Is a Risk Factor for Progression of MGUS

English

Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma

English

Single-Nucleotide Polymorphism Rs1052501 Associated With Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

English

Melphalan and Prednisone Versus Melphalan, Prednisone and Thalidomide for Elderly and/or Transplant Ineligible Patients With Multiple Myeloma: A Meta-Analysis

English

Racial Disparities in the Prevalence of Monoclonal Gammopathies: A Population-Based Study of 12 482 Persons From the National Health and Nutritional Examination Survey

English

Response to Salvage Therapies and Outcome in Patients With Multiple Myeloma Relapsing After Pomalidomide Therapy

English

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

English

Changes in Uninvolved Immunoglobulins During Induction Therapy for Newly Diagnosed Multiple Myeloma

English

Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S V Rajkumar

Polymorphism of the Erythropoietin Gene Promotor and the Development of Myelodysplastic Syndromes Subsequent to Multiple Myeloma

Suppression of Uninvolved Immunoglobulins Defined by Heavy/Light Chain Pair Suppression Is a Risk Factor for Progression of MGUS

Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma

Single-Nucleotide Polymorphism Rs1052501 Associated With Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Melphalan and Prednisone Versus Melphalan, Prednisone and Thalidomide for Elderly and/or Transplant Ineligible Patients With Multiple Myeloma: A Meta-Analysis

Racial Disparities in the Prevalence of Monoclonal Gammopathies: A Population-Based Study of 12 482 Persons From the National Health and Nutritional Examination Survey

Response to Salvage Therapies and Outcome in Patients With Multiple Myeloma Relapsing After Pomalidomide Therapy

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

Changes in Uninvolved Immunoglobulins During Induction Therapy for Newly Diagnosed Multiple Myeloma

Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib